Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01503268

Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders: The ACTUAL Study

Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Eastbourne General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation (AF) is a common but often distressing condition. It can be treated with medications, but these are not always effective or tolerated. Ablation is a well-recognised technique that is recommended for those with symptomatic AF who have failed medical therapy. Ablation can be performed in a number of ways. In percutaneous ablation, ablation is performed via tiny punctures in the skin in the groin. In minimally-invasive thoracoscopic ablation, ablation is performed under general anaesthetic via very small incisions in the chest wall. Because AF can be intermittent, the only reliable way to look for it is with long-term ECG monitoring. A safe and practical way to do this is to use implantable loop recorders (ILRs). In this study, the investigators are trying to see if minimally-invasive thoracoscopic ablation is better than percutaneous ablation, and in turn if they are better than Direct current cardioversion (DCCV), using ILRs to monitor AF.

Conditions

Interventions

TypeNameDescription
DEVICEImplantation of implantable loop recorderAn implantable loop recorder (ILR) will be used to assess atrial fibrillation(AF) before and after DCCV or ablation, unless there is a pre-existing ILR or permanent pacemaker capable of continuous monitoring for occurrence of AF.
PROCEDUREPercutaneous ablation of atrial fibrillationCatheter-based percutaneous ablation of atrial fibrillation
PROCEDURESurgical ablation of atrial fibrillationMinimally-invasive thoracoscopic surgical ablation of atrial fibrillation

Timeline

Start date
2012-11-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2012-01-04
Last updated
2013-06-21

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01503268. Inclusion in this directory is not an endorsement.